Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Work In Process: 2013-2025

Historic Work In Process for Phibro Animal Health (PAHC) over the last 12 years, with Sep 2025 value amounting to $25.8 million.

  • Phibro Animal Health's Work In Process rose 2.98% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 2.98%. This contributed to the annual value of $28.0 million for FY2025, which is 18.82% up from last year.
  • Latest data reveals that Phibro Animal Health reported Work In Process of $25.8 million as of Q3 2025, which was down 7.85% from $28.0 million recorded in Q2 2025.
  • Phibro Animal Health's 5-year Work In Process high stood at $28.0 million for Q2 2025, and its period low was $10.1 million during Q3 2021.
  • For the 3-year period, Phibro Animal Health's Work In Process averaged around $25.0 million, with its median value being $25.2 million (2023).
  • Per our database at Business Quant, Phibro Animal Health's Work In Process dropped by 2.74% in 2021 and then surged by 72.97% in 2022.
  • Phibro Animal Health's Work In Process (Quarterly) stood at $11.9 million in 2021, then surged by 68.34% to $20.0 million in 2022, then rose by 25.27% to $25.1 million in 2023, then increased by 5.05% to $26.3 million in 2024, then grew by 2.98% to $25.8 million in 2025.
  • Its last three reported values are $25.8 million in Q3 2025, $28.0 million for Q2 2025, and $27.4 million during Q1 2025.